Health Sciences In The Media

Mohab Ibrahim, MD, PhD, medical director of the UArizona Comprehensive Pain and Addiction Center, explains how different topical pain medications like lidocaine work.

A $2.1 million grant from the National Institutes of Health will allow University of Arizona Health Sciences researchers to study the links between knee structure changes and clinical outcomes in people with osteoarthritis.

Mask-wearing in childcare programs is linked with fewer COVID-19-related program closures, new data released suggest. Paloma Beamer, PhD, a professor of public health and exposure scientist at the Mel and Enid Zuckerman College of Public Health, is quoted.

This article cites a University of Arizona Health Sciences study that found 67 percent of people who recovered from “mild or moderate” infections experienced long COVID symptoms more than 30 days after their positive test.

In December, the FDA authorized Evusheld, a monoclonal antibody combination designed to prevent COVID-19 in people who are seriously immunocompromised or who have had serious adverse reactions to COVID-19 vaccines. Deepta Bhattacharya, PhD, a professor of immunobiology at the College of Medicine –Tucson, is interviewed.

Rubin Naiman, PhD, a clinical assistant professor of medicine and dream expert at the UArizona Andrew Weil Center for Integrative Medicine, says dreaming is healing. It’s kind of a "digestive process” — taking difficult experiences, like a breakup, and spelling them out to provide understanding.

Innovations in Healthy Aging, is a collaboration across campus to enhance the lives of older adults through integration, partnerships, research and education. Kathleen Insel, PhD, RN, a professor at the UArizona College of Nursing, said they are finding aging isn’t a period of decline but a positive experience.

Agnes Attakai, MPA, director of Health Disparities Outreach and Prevention Education at the Mel and Enid Zuckerman College of Public Health, will speak at Health Affairs’s Racism & Health Virtual Symposium on Feb. 8.

Continuing coverage: Mohab Ibrahim, MD, PhD, medical director of the UArizona Health Sciences Comprehensive Pain and Addiction Center, said he is seeing mostly diffuse muscle and joint pain. Less common pain complaints have included headache and neuropathic pain.

COVID-19 infections due to the Omicron variant are slowing nationwide, but some states are still seeing high rates of hospitalizations, like Arizona. Frank LoVecchio, DO, MPH, a professor and emergency medicine physician from the College of Medicine – Phoenix, shares his experience working in the ER in Phoenix.